STOCK TITAN

Browning West and Glenn Chamandy Comment on Gildan Activewear’s Defensive and Reactionary Board Refreshment

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Browning West and Glenn Chamandy criticize Gildan Activewear's defensive board refreshment, emphasizing failures, and the need to reinstate Glenn as CEO for shareholder returns. Browning West seeks to elect a new slate of directors to the Board.
Browning West e Glenn Chamandy criticano il rinnovamento difensivo del consiglio di amministrazione di Gildan Activewear, sottolineando le mancanze e la necessità di reintegrare Glenn come CEO per incrementare i rendimenti agli azionisti. Browning West mira a eleggere una nuova lista di direttori per il consiglio.
Browning West y Glenn Chamandy critican la renovación defensiva de la junta directiva de Gildan Activewear, enfatizando los fallos y la necesidad de reinstaurar a Glenn como CEO para mejorar los retornos a los accionistas. Browning West busca elegir una nueva plana de directores para la Junta.
브라우닝 웨스트와 글렌 샤만디는 길단 액티브웨어의 방어적인 이사회 개편을 비판하며, 실패를 강조하고 주주 수익을 위해 글렌을 CEO로 재임명할 필요성을 강조합니다. 브라우닝 웨스트는 이사회에 새로운 이사진을 선출하고자 합니다.
Browning West et Glenn Chamandy critiquent le rafraîchissement défensif du conseil d'administration de Gildan Activewear, en soulignant les échecs et la nécessité de réintégrer Glenn en tant que PDG pour améliorer les retours aux actionnaires. Browning West cherche à élire une nouvelle série de directeurs au conseil.
Browning West und Glenn Chamandy kritisieren die defensive Erneuerung des Verwaltungsrates von Gildan Activewear, betonen die Misserfolge und die Notwendigkeit, Glenn als CEO wieder einzusetzen, um die Aktionärsrenditen zu verbessern. Browning West strebt an, eine neue Liste von Direktoren für den Vorstand zu wählen.
Positive
  • Browning West and Glenn Chamandy highlight Gildan Activewear's Board failures and defensive maneuvers.
  • The Board's failure to reinstate Glenn as CEO despite shareholder demands is criticized.
  • The newly appointed directors are considered less qualified than Browning West's candidates.
  • Browning West aims to deliver a stock price of over $60 USD by 2025 and $100 USD within five years.
  • The Board's excessive spending on entrenchment tactics is questioned.
  • Glenn Chamandy seeks support from Browning West's slate for the best Board composition.
  • Browning West is urging shareholders to vote for their highly qualified director candidates at the upcoming Annual Meeting of Shareholders on May 28, 2024.
Negative
  • The Board's reluctance to reinstate Glenn as CEO despite shareholder demands could lead to continued unrest.
  • The reactive sale process collapse could impact the company negatively in the long term.
  • The ongoing board disputes and entrenchment tactics may create uncertainty among investors.
  • The potential disruption caused by the Board's actions could affect the company's performance and shareholder value.

Gratified That Board Leadership, Including the Chairman and Every Committee Chair, Has Seemingly Acknowledged Their Many Failures by Resigning En Masse

Question Why the Board Has Gone to Such Lengths to Allow Vince Tyra to Remain CEO Despite His Track Record of Value Destruction and Amid Unprecedented Shareholder Calls to Reinstate Glenn Chamandy

Remind Shareholders That Electing the Full Browning West Slate is the Only Clear Path to Reinstating Glenn Chamandy as CEO to Generate Outstanding Shareholder Returns

LOS ANGELES--(BUSINESS WIRE)-- Browning West, LP (together with its affiliates, “Browning West” or “we”), which is a long-term shareholder of Gildan Activewear Inc. (NYSE: GIL) (TSX: GIL) (“Gildan” or the “Company”) that beneficially owns approximately 5.0% of the Company’s outstanding shares and Glenn Chamandy, Gildan’s co-founder and former CEO, today issued the following statements regarding the Company’s defensive maneuver to add replacement directors to its Board of Directors (the “Board”).

Usman S. Nabi and Peter M. Lee of Browning West commented:

“The Board’s list of failures grows by the week: beginning with its botched succession process, followed by numerous diligence failures, a reactive and misguided sale process, and now a desperate and defensive Board refreshment. The most glaring omission in the Board’s latest maneuver is its failure to reinstate Glenn as CEO and its unwavering commitment to Vince Tyra – including from new directors – despite his record of value destruction and poor personal judgment. The reinstatement of Glenn has been a central and consistent demand from an unprecedented mass of shareholders, which the Board refuses to acknowledge in favor of its own interests. It is also clear that the newly announced directors are objectively less qualified than Browning West’s director candidates, who possess best-in-class track records of value creation and relevant experience. It is critical for shareholders to understand that only through the appointment of our full slate can Glenn return as CEO and implement our superior value creation plan, which is designed to deliver a stock price of over $60 USD by the end of 2025 and $100 USD within five years.

Contrary to the Board’s false and misleading statements, support for Glenn and our full slate is growing and stronger than ever. While we are gratified that every single incumbent director responsible for the Board’s many failures is stepping aside, we are disappointed that it is due in part to the Board’s relentless focus on protecting Vince Tyra to avoid accountability. We remain steadfast in our belief that the election of each of our eight highly qualified directors and Glenn’s return as CEO represent the best path forward for Gildan. Considering the Board has a history of diligence failures and recruiting underqualified executives, it has not earned the right to hand-select its own replacement directors. Finally, we believe that today’s announcement was likely triggered by the collapse of the Board’s reactive sale process, which it is clearly trying to bury in the 2,500+ word press release. It is time for Gildan’s Board to immediately cease its excessive and wasteful spending of shareholder capital on its misguided sale process and numerous entrenchment tactics.”

Glenn Chamandy, Gildan’s co-founder and former CEO, commented:

“When I return to Gildan as CEO, I want to be supported by the highest quality Board with relevant experience. I have spent time with members of the Browning West slate and believe they possess necessary track records of value creation, expertise in successful succession planning and corporate governance, and relevant operational, industry, and ESG experience. In addition, it is critical that I am supported by a Chairman who has a strong record as an operating CEO and Chair, which Mike Kneeland clearly possesses, and that there is an owners’ mindset in the boardroom, which Peter Lee of Browning West clearly possesses. The Browning West slate represents the best Board for all Gildan stakeholders.”

As a reminder, Browning West is seeking to elect eight highly qualified and independent director candidates to Gildan’s Board at the Annual Meeting of Shareholders on May 28, 2024. Browning West’s director candidates possess strong track records of value creation, expertise in successful succession planning, relevant industry and governance experience, as well as proven management and board service pedigrees in Canada and the U.S.

Shareholders are encouraged to visit www.SuperchargeGildan.com to download a copy of the slate’s operating plan, learn how to vote for Browning West’s slate of highly qualified director candidates, and sign up for important campaign updates. Visit SEDAR+ (www.sedarplus.ca) to review a copy of Browning West’s information circular and other relevant materials.

Disclaimer for Forward-Looking Information

Certain information in this news release may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking statements and information generally can be identified by the use of forward-looking terminology such as “outlook,” “objective,” “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “plans,” “continue,” or similar expressions suggesting future outcomes or events. Forward-looking information in this news release may include, but is not limited to, statements of Browning West regarding (i) how Browning West intends to exercise its legal rights as a shareholder of the Company, and (ii) its plans to make changes at the Board and management of the Company.

Although Browning West believes that the expectations reflected in any such forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements including, without limitation, the risks that (i) the Company may use tactics to thwart the rights of Browning West as a shareholder and (ii) the actions being proposed and the changes being demanded by Browning West, may not take place for any reason whatsoever. Except as required by law, Browning West does not intend to update these forward-looking statements.

Advisors

Olshan Frome Wolosky LLP is serving as legal counsel, Goodmans LLP is serving as Canadian legal counsel, and IMK is serving as Quebec legal counsel. Longacre Square Partners is serving as strategic advisor and Pelican PR is serving as public relations advisor. Carson Proxy is serving as proxy advisor.

About Browning West, LP

Browning West is an independent investment partnership based in Los Angeles, California. The partnership employs a concentrated, long-term, and fundamental approach to investing and focuses primarily on investments in North America and Western Europe.

Browning West seeks to identify and invest in a limited number of high-quality businesses and to hold these investments for multiple years. Backed by a select group of leading foundations, family offices, and university endowments, Browning West’s unique capital base allows it to focus on long-term value creation at its portfolio companies.

Browning West

info@browningwest.com

310-984-7600



Longacre Square Partners

Charlotte Kiaie / Scott Deveau, 646-386-0091

browningwest@longacresquare.com



Pelican PR

Lyla Radmanovich / Mélanie Tardif, 514-845-8763

media@rppelican.ca



Carson Proxy

Christine Carson, 416-804-0825

christine@carsonproxy.com

Source: Browning West, LP

FAQ

Why are Browning West and Glenn Chamandy critical of Gildan Activewear's Board refreshment?

Browning West and Glenn Chamandy believe the Board's latest actions represent defensive maneuvers and highlight a series of failures.

What is the key demand from shareholders regarding Glenn Chamandy's reinstatement?

Shareholders are demanding the reinstatement of Glenn Chamandy as CEO to drive outstanding shareholder returns.

What is Browning West's plan regarding the new slate of directors for Gildan's Board?

Browning West aims to elect eight highly qualified and independent director candidates to Gildan's Board at the upcoming Annual Meeting of Shareholders on May 28, 2024.

What stock price targets does Browning West aim to achieve through its value creation plan?

Browning West aims to deliver a stock price of over $60 USD by the end of 2025 and $100 USD within five years through its value creation plan.

How can shareholders support Browning West's initiative for Gildan's Board?

Shareholders are encouraged to visit www.SuperchargeGildan.com to download the slate's operating plan, learn how to vote for Browning West's director candidates, and receive campaign updates.

Gildan Activewear Inc.

NYSE:GIL

GIL Rankings

GIL Latest News

GIL Stock Data

5.92B
149.16M
2.03%
89.79%
0.77%
Hosiery and Sock Mills
Manufacturing
Link
United States of America
Montreal

About GIL

gildan is a leading supplier of quality branded basic family apparel, including t-shirts, fleece, sport shirts, underwear, socks, hosiery, and shapewear. the company sells its products under a diversified portfolio of company-owned brands, including the gildan®, gold toe®, anvil® and comfort colors® brands and brand extensions, as well as the secret®, silks® and therapy plus™ brands. the company also has the u.s. sock license for under armour®, and licenses for the mossy oak® and new balance® brands. the company distributes its products in printwear markets in the u.s. and canada, as well as in europe, asia-pacific and latin america. the company also markets its products to a broad spectrum of retailers primarily in the u.s. and canada. the company also manufactures for select leading global athletic and lifestyle consumer brands. gildan owns and operates vertically-integrated, large-scale manufacturing facilities which are primarily located in central america and the caribbean basin